Lymphoma

Latest News

Brentuximab Vedotin Improves Efficacy in Classical Hodgkin Lymphoma
Brentuximab Vedotin Improves Efficacy in Classical Hodgkin Lymphoma

June 1st 2024

Brentuximab vedotin led to unprecedented progression-free survival for patients with classical Hodgkin lymphoma.

Findings from the TRANSCEND NHL 001 trial support the FDA approval of lisocabtagene maraleucel in relapsed/refractory mantle cell lymphoma.
FDA Approves Liso-cel in Relapsed/Refractory Mantle Cell Lymphoma

May 30th 2024

Data from the ALLELE trial support the application for tabelecleucel in patients with EBV-positive post-transplant lymphoproliferative disease.
Developers Submit BLA for Tabelecleucel in EBV+ Lymphoproliferative Disease

May 21st 2024

Data from the TRANSCEND-FL trial support the accelerated approval of lisocabtagene maraleucel in relapsed/refractory follicular lymphoma.
Liso-cel Earns FDA Accelerated Approval in R/R Follicular Lymphoma

May 15th 2024

Data also highlight a favorable overall survival trend with the acalabrutinib regimen in the phase 3 ECHO trial.
Acalabrutinib Combo Yields PFS Improvement Vs SOC in Mantle Cell Lymphoma

May 3rd 2024

Latest CME Events & Activities

Patient, Provider, and Caregiver Connection™: Individualizing Care for Patients with Schizophrenia—Understanding Patient Challenges and the Role of Innovative Treatment

View More

Improving Outcomes in Autoimmune Hemolytic Anemias at the Intersection Between Hematology and Oncology Care

View More

B-Cell Tumor Board: Rendering Real World Personalized Treatment Plans in CLL/SLL and MCL Through the Lens of Emerging BTKi Evidence

View More

Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer

View More

Translating New Evidence into Treatment Algorithms from Frontline to R/R Multiple Myeloma: How the Experts Think & Treat

View More

Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?

View More

Medical Crossfire®: The Experts Bridge Recent Data in Chronic Lymphocytic Leukemia With Real-World Sequencing Questions

View More

Community Practice Connections™: Pre-Conference Workshop on Immune Cell-Based Therapy

View More